Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Elliott

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.
American Heart Journal|May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and designGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
JAMA|August 14, 2024
Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical TrialGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Immunotherapy Advances|January 24, 2022
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetesAshish K Marwaha, Samuel Chow, Anne M Pesenacker, et al.
American Heart Journal|May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and designGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
JAMA|August 14, 2024
Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical TrialGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Pageof 8